Michael Sullivan.jpg

Michael James Sullivan MB ChB DCH FRACP PhD
Formerly from Christchurch, Michael is now Head of the Solid Tumour Program at the Royal Children’s Hospital in Melbourne and a Fellow in the Murdoch Children’s Research Institute. He was recently elected to be Continental President for the International paediatric Oncology Society.
Michael’s research interests are focused on the genetics and epigenetics of childhood solid tumour and brain tumours - work he continues to do in collaboration with New Zealand researchers.
He has a special interest in childhood liver cancer and is a member of the International Childhood Liver Cancer Clinical Trial Consortium.
Michael shares with his Christchurch colleagues a long standing commitment to supporting the care of children with cancer in the Pacific.

Spencer Beasley.jpg

Spencer W Beasley ONZM, MB ChB (Otago), MS (Melb), FRACS, FAICD
Spencer Beasley received his undergraduate training at the University of Otago, and has a Fellowship of the Royal Australasian College of Surgeons endorsed in general surgery and paediatric surgery. He is the Clinical Director of the Department of Paediatric Surgery, and former Chief of the Child Health service at Christchurch Hospital, Canterbury District Health Board in Christchurch.  His academic appointment is to the University of Otago, New Zealand as Clinical Professor of Paediatric Surgery.  Prior to moving to New Zealand in 1996 he was a consultant paediatric surgeon and paediatric urologist at the Royal Children’s Hospital, Melbourne, Australia. He has a Master of Surgery, University of Melbourne.
He has been President of the Australasian Association of Paediatric Surgeons and is current President of the New Zealand Society of Paediatric Surgeons.  He was the Australian representative on the Board of Governors of the Pacific Association of Pediatric Surgeons from 1994-1999.  He has served on several Technical Advisory Groups to the Ministry of Health. He has been a section editor of the ANZ Journal of Surgery and is a senior editor of the Journal of Paediatrics and Child Health. He has authored 9 books on paediatric surgery and over three hundred peer-reviewed articles. He ran an active research unit (studying the embryogenesis and the role of Sonic Hedgehog in oesophageal atresia, and iPS differentiation into peristalsing smooth muscle) until the Christchurch earthquakes in 2011 damaged his research facilities. He is a member of the Male Champions of Change STEM group achieving gender equity and increasing diversity. He has provided pro bono services to Vanuatu as part of the Pacific Island Program for ten years.
He has a longstanding interest in surgical education. He was formerly Chair of the Board of Paediatric Surgery, Chair of the Board of Surgical Education and Training of the Royal Australasian College of Surgeons (RACS), New Zealand Censor, Deputy Censor-in-Chief, Chair of the RACS Professional Development committee and Elected Councilor of RACS. In 2016-7 he was the Vice-President of the Royal Australasian College of Surgeons. He is a serving member of the NZ National Board. He was an examiner in paediatric surgery for the RACS for 10 years before becoming the Chair of the Court of Examiners. His interests lie in the assessment of higher cognitive decision-making and professional judgement as it applies to surgery.
Since moving to Christchurch 22 years ago he has developed a regional specialist paediatric surgical service to the South Island: he and colleagues provide regular clinics and operating to each of the South Island public hospitals. In 2018 he became an Officer of the New Zealand Order of Merit in recognition of his services to paediatrics.

Steohen Andrew.png

Stephen Andrew O'Connell
Stephen is both Treasurer and a Trustee of the Children’s Cancer Research Trust and was involved in the initial formation of the trust and its subsequent registration as a charitable entity in 2007. 
Stephen is a director in Accounting and Business Advisory firm O’Connell and Co. and specialises in rural accounting, residential and commercial property development, carbon forestry and carbon credits.

Amnada Lyver.jpg

Dr Amanda Lyver 
Amanda undertook her specialist training in Christchurch and Vancouver. She is currently the Clinical Director of Paediatric Oncology at Christchurch Hospital.  She has a sub-specialty interest in Paediatric Palliative Care with a post-graduate qualification from Flinders University and sits on the National Reference Group for Paediatric Palliative Care and the South Island Alliance.
Amanda is mum to two children.

Andrew Didgshun.jpg

Andrew Dodgshun
Andrew is a Paediatric Oncologist based in Christchurch. He trained as an undergraduate at the University of Otago and began training in paediatrics at Christchurch Hospital. He moved to Melbourne to complete a clinical fellowship in Paediatric Oncology at the Royal Children’s Hospital.

He has a special interest in childhood brain tumours, particularly gliomas and discovered an unanticipated passion for research into this area culminating in a Master of Philosophy (Research) degree with a thesis focused on paediatric glioma. He has published widely in this area and has been involved in international research collaborations with Dana Farber Cancer Institute in Boston, SickKids Hospital in Toronto and DKFZ in Germany. Current projects include investigating the efficiency of methylation profiling in the diagnosis of rare diseases and risk factor analysis in newly described brain tumour entities.

Me for photo.jpg

Siobhan Cross 
Siobhan Cross is a paediatric haematologist who trained in New Zealand, England and Australia before taking up a position in Christchurch.  she has published in the use of PET scans in paediatric cancer, familial cancer syndromes, enrollment barriers in clinical trials and cancer registries. She is a member of the Children’s Oncology Group cancer control steering committee and current chair of the ANZCHOG leukaemia subgroup. Her current research interests are in post treatment immunisations and pharmacogenetic differences in drug metabolism in anti-leukaemic therapy.